Pharmaceutical Caps and Closures Market
Market Insights on Pharmaceutical Caps and Closures covering sales outlook, demand forecast & up-to-date key trends
Pharmaceutical Caps and Closures Market by Product type (Screw Caps & Closure, Snap Caps & Closure, Push-Pull Caps & Closure, Stopper & Seals), Functionality (Child Resistant, Tamper-evident), Material, Drug Modality, Therapeutic class, End Users & Region - Forecast to 2021-2031
Key Highlights From Report
-
Which is the most lucrative market for pharmaceutical caps and closures?
The U.S. currently leads the global market for pharmaceutical caps and closures. Sales in the U.S. will account for over 89% of the North America market throughout the forecast period.
-
Which is the most commonly used type of pharmaceutical caps and closures?
Screwcap and closures have emerged dominant in terms of product type and are expected to account for more than 46% of the market through 2031.
-
Which is the most common application for pharmaceutical caps and closures?
Anti-cancer drugs are exhibiting faster growth in demand at 7.5% CAGR for pharmaceutical caps and closures.
-
Which drug modality contributes to maximum sales of pharmaceutical caps and closure?
Small molecule drug modalities are showing consistency in growth and are expected to account for approximately 60% of the global market by 2031. Rising demand for standardization will drive sales in this category.
-
Who is the leading end-user of pharmaceutical caps and closures?
Pharmaceutical and biotechnology companies are leading end-users in the market and are expected to hold a share of 52.5% through 2021 owing to their advanced medical facilities and higher footfall of patients.
-
Which materials are preferred for the production of pharmaceutical caps and closures?
Plastics will account for more than 64% of the market in 2031 owing to their flexibility in function and low costs of production and sourcing.
Let us know your requirement to get
100% FREE customization
Key Points Covered in Pharmaceutical Cap and Closure Market Study
- Market estimates and forecast 2015-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Pharmaceutical Caps and Closures Market and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Pharmaceuticals Caps and Closures Market Outlook Compared to 2021-2031 Forecast
Until recently, owing to a lack of awareness about safety concerns, the production of pharmaceutical caps and closures was fairly limited. According to Future Market Insights FMI), the sales of pharmaceutical caps and closures have grown at a 4.7% CAGR between 2016 and 2020.
The increasing demand for safe and easy packaging has encouraged innovations in the field of pharmaceutical caps and the closures market. The demand for child-proof packaging owing to concerns over accidental consumption is rising. This also will have a positive impact on the market.
According to the National Health Service (NHS), a majority of children under five years are affected by unwanted harmful drugs owing to improper closing of containers.
With growing economies and the expansion of health care and insurance systems, the demand for pharmaceutical products is escalating strongly. It is estimated that the global pharmaceutical market will grow at 3-6% annually in the coming years.
Focus on effective packaging to minimize the risk of accidents and spoilage of pharmaceutical products, the demand in the market is expected to increase. In the U.S., the spending on medicines is increasing owing to new product adoption. Medical spending in Japan exceeded US$85 Bn in 2019. The same for China touched US$136 Bn.
The usage of medicines has jumped by 24% in 2020 as compared to 2015. Developed economies will continue to use a larger volume of prescribed medicines. Emerging countries will use more generics and over-the-counter alternatives.
With pharmaceutical spending consistently rising in developed countries, the demand for pharmaceutical caps and closures is expected to rise.
The COVID-19 pandemic has changed priorities in the national healthcare process and spending. However, it is considered to have a short-term negative impact on the pharmaceutical caps and closures market. Future Market Insights expects the global pharmaceuticals caps and closures market to rise at 5.7 % CAGR between 2021 and 2031.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow are Light Weight Packaging Formats Affecting the Pharmaceutical caps and Closures Market?
Lightweight packaging material have a higher acceptance rate among consumers. Lightweight closures made from resins, which results in lower plastic usage, while meeting the need of environment friendly products.
Considering both economic and social benefits, light-weight packaging has become increasingly acceptable, while innovation and research are seen as key to the future of the market.
How are Investments in Product Development Influencing Growth?
Innovation in the field of plastic packaging has been aiding new product launches in the market. Researchers are focusing on the objective of reduction in development costs.
Extensive research has been conducted using samples from across the world to create unique products which are cost friendly, profitable, and made with limited resources.
For Instance, In March 2021, Drug Plastics & Glass Co Inc. filed a patent for new closure designs. The SecuRx Dosage Cap is ideal for cough syrups, antacids, vitamins, antibiotics, cannabis beverages, and more, and they deliver accurate, user-friendly liquid doses which can be mass produced at a lower cost.
Innovations such as these are expected to have positive impact on the market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
How are Stringent Regulations Restricting Market Growth?
Stringent rules and regulations associated with the grade of plastics used in end-use industries, especially in the food and beverages and pharmaceuticals industries might hamper market growth.
Also, in the U.S. regulations enacted by the Food and Drug Administration (FDA) have made it compulsory to implement child-resistant closures. This will create lucrative prospects for sales in the pharmaceutical industry.
However, smaller companies might find it difficult to adhere to such stringent regulations. Machineries required for ascertaining stringent guidelines are often cost-intensive, which might discourage smaller players. This in turn can have a negative impact on the market.
What are the Key Opportunities for Pharmaceutical Cap and Closure Manufacturers?
Today, consumers are looking for products that are easy to access, easy to use, with higher preference for self resealing offerings. These factors are creating notable opportunities for manufacturer to develop consumer-friendly products.
Increasing investments in the healthcare sector in emerging countries is anticipated to boost the demand for pharmaceutical caps & closures. Local and regional players are expanding their distribution networks and manufacturing facilities to boost their business portfolio across the globe.
Increasing government initiatives for research and development is expected to provide create significant opportunities in the pharmaceutical caps & closures market.
Country-wise Insights
How Lucrative is the Opportunity in the U.S?
In the U.S., the spending on medicines has steadily increased over the years , driving the adoption of new cap and closure offerings. The U.S. will hold over 89% of the pharmaceutical caps and closures market in North America. Also, regulations implemented by the FDA to ascertain child-resistant closures in the pharmaceutical industry have contributed to growth prospects.
Implementation of such laws are boosting research and development among manufacturers in North America. The year 2020 also witnessed vaccine launches for the COVID-19 pandemic. Increasing production and sales of vaccines will drive the pharmaceutical caps & closures market.
Moreover, the increasing prevalence of chronic diseases like cardiovascular disorders, cancer, and others is fuel demand for for various medications. This will in turn fuel the demand for effective packaging solutions in the pharmaceutical sector, creating opportunities for the pharmaceutical caps and closure sales.
What are the Factors Driving Revenue Generation in the U.K.?
The U.K. will account for over 25% of the Europe market through the assessment period ending in 2031. Common tech developments, the demand for extensive product portfolios, and improvements in drug development pipelines and production capacities are key factors speeding growth in the U.K. market for pharmaceutical caps and closures.
New acquisitions have been driven by the need to widen portfolios for nonexclusive clean injectables in the U.K. market. For Instance, in January 2020, Cyrano Berry launched its advanced molding technology, to create extremely lightweight components to deliver reliable performance to safeguard product integrity, offer ease drug administration, and improve patient safety.
What are the Factors Restricting Pharmaceutical Caps and Closure Production in Germany?
The Germany market will exhibit a 6.7% CAGR thoughout the forecast period. Regulatory guidelines are relatively stricter in Germany. As a result, achieving approvals is harder. The EMA guideline covers the exact requests for packaging materials which is in direct contact pharma products or drugs.
These guidelines need to be met for new registration applications. As a result of stringent guidelines, elastomeric closures are increasingly used in injectable pharmaceutical products and delivery systems to ensure component functionality and suitability of parenteral products.
Plastic packaging systems create concerns associated to potential safety effects with the production of drugs and biopharmaceuticals. As a result, stringent regulation for all type of closures in Germany is restraining the market.
Favorable Policies Driving Japan Market
Increasing healthcare spending has improved the quality of healthcare, while boosting the demand for pharmaceutical products in countries like Japan. The Japan market will accounts for more than 45% of the sales registered East Asia market in 2021.
In Japan, the total annual pharmaceutical spending equals US$93 billion. Moreover, the government of Japan provides for healthcare spending of around 40% via the national insurance schemes. Japan’s pharmaceutical sector has been forecast to grow considerably in the coming years, paving way for the expansion of the pharmaceutical caps and closures market.
What is Scope of Growth of Pharmaceutical Caps and Closures Market in Argentina?
Increasing investments in the healthcare sector is anticipated to boost the demand of pharmaceutical caps & closures. Increasing government initiatives for research and development is expected to provide significant opportunities in Argentina.
The market for pharmaceutical caps and closures in Argentina is exhibiting 4% CAGR, and is expected to account for more than 11% of the Latin America market throughout the projection period. Encouraged by lucrative prospects, several market players are likely to expand their presence in the country.
For Instance, in September 2020, Bericap GmbH and Co KG established a new plant in Argentina and started a production facility in Malaysia as a hub for further expansion in Southeast Asia.
Category-wise Insights
Why is Child Resistant Driving Revenue by Functionality?
A relatively higher adoption rate is witnessed in child resistance closures owing to their effectiveness in preventing accidental consumption. The segment is expected to account for 61% market share in 2021.
Also, lower costs of these closures result in higher revenue generation in the global pharmaceuticals caps and closures market. However, tamper-resistant products will reflect a higher rate of growth owing to concerns over counterfeiting.
What is the Market Share of Screw Caps and Closure?
Screw caps and closures will continue to dominate the market during the forecast period. According to Future Market Insights, the segment is expected to hold around 46% of the market share through the end of 2031.
Screw caps and closures offer various benefits to manufacturers in the supply chain and are helpful in patient compliance. Besides this, they offer help in offering longer shelf life and sustainability of products.
Why are Plastics Preferred for Pharmaceutical Caps and Closures?
Plastic closures are lightweight, cost-effective, and easy to manufacture which will enable the plastic segment to account for over 64% of the market by the end of 2031. Lightweight packaging materials have higher acceptance rates among consumers.
Lightweight closure made from resins results in lower plastic usage while also complying with the recent rise in demand for environment-friendly products.
On the other hand, the manufacturing cost is also reduced due to the usage of resin in lightweight caps. Therefore, considering both economic and social benefits, offering lightweight has become a key aspect for production. This will also influence the material used for manufacturing pharmaceutical caps and closures.
How are Prescription (Rx) Caps and Closures Set to Fare?
Most pharmaceutical and biopharmaceutical drugs for chronic diseases are available only with prescriptions. As a result, prescribed drug closures will account for a market share of 76% by the end of 2031.
Over-the-counter (OTC) alternatives are likely to witness increasing opportunities, especially in developing countries, owing to easier access to consumers. The trend is likely to continue in the upcoming years, fuelling sales in the OTC segment.
How are Small Molecule Drug Modalities Contributing to Growth?
Most of pharmaceutical companies are focusing on the development of small molecule and biopharmaceutical packaging with improved compatibility with most container closure designs.
This segment is estimated to be valued at US$ 2.33 Bn by the end of 2031. Research into biopharmaceuticals will also create important growth opportunities.
Why are Pharmaceutical & Biotechnology Exhibiting High Demand for Pharmaceutical Caps and Closures?
Most pharma and biotech companies are focusing on pharma products with higher brand awareness which is particularly true in developed countries. Pharmaceutical and biotechnology companies are likely to account for over 55% of sales in the market in 2021.
Which Therapeutic Class is Aiding Increasing Sales of Pharmaceutical Caps and Closures?
Anticancer drugs currently lead the market in terms of therapeutic class, accounting for a share of over 20% in 2021. The increasing prevalence of cancer around the world will fuel demand in the segment.
According to the International Agency for Research on Cancer (IARC), by 2040, the world is expected to register 27.5 million new cancer cases and 17.3 million cancer deaths. According to the WHO, the risk of developing cancer before the age of 75 years is about 20.2% and the risk of dying from cancer before the age of 75 years is about 10.6%.
The demand for cancer treatment medications is increasing at a high pace, which is expected to create growth opportunities in the market. The demand for pharmaceutical caps and closures for anti-cancer drugs is forecast to rise at a CAGR of 7.5% between 2021 and 2031.
Competitive Landscape
Manufacturers in the pharmaceutical caps and closures market are primarily aiming to carry out strategic collaborations and R&D to consolidate growth in a competive and fragmented market.
For Instance, In November 2019, the MENSHEN Gmbh launched a new sustainable closure solution that was specially designed for the pharmaceuticals industry.
In January 2020, Berry group launched a new product Cyrano Berry’s advanced molding technology to create extremely lightweight components, which still deliver reliable performance to safeguard product integrity, ease drug administration, and improve patient safety.
In October 2020, West Pharmaceutical Serivese launched Vial2Bag Advanced 20mm Admixture Device, which enables reconstitution and transfer of a drug between a vial and an IV bag.
The company is strategically making promotional plans for its established prescription brands to increase their awareness within the prescription market Its ‘Get Old’ campaign also makes a frequent appearance on the main company feeds and through its own Twitter and Facebook page.
Some of the leading companies in the pharmaceutical caps and closures market include:
- Berry Global Inc.
- Amcor Plc
- Aptar, Inc.
- Closure Systems International, Inc.
- O.Berk Company, LLC
- Bericap GmbH and Co KG
- UNITED CAPS
- CL Smith Company
- Georg MENSHEN GmbH & Co. KG
- WestRock Company
- West Pharmaceutical Services, Inc
- Drug Plastics & Glass Co Inc.
- Gerresheimer AG
- DWK Life Sciences GmbH
- Parekhplast India Limited
- Parshva Exim Limited
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD billion for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Key Segments Covered |
Product, Functionality, Material, Availability, Drugg Modality, Therapeutic Class, End-Users, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Phramacutical caps and Closures Services Market by Category
Product type
- Screw Caps & Closure
- Snap Caps & Closure
- Push-Pull Caps & Closure
- Stopper & Seals
- Others
Functionality
- Child Resistant
- Tamper-evident
Material type
- Plastic
- Elastomer
- Metal
Avalability
- Prescription (Rx) Pharmaceuticals
- "Over-the-Counter (OTC) Pharmaceuticals"
Drug Modality
- Small Molecule (Synthetic Drugs)
- Biopharmaceuticals
Therapeutic class
- Anticancer Drugs
- Anti-infective Drugs
- Anti-viral Drugs
- Anti-bacterial Drugs
- Anti-fungal Drugs
- Others
- Cardiovascular Drugs
- Anti-inflammatory Drugs
- Analgesics Drugs
- Anti-diabetics
- Ophthalmic Drugs
- Neurological Drugs
- Others
End Users
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMO)
- Contract Research Organizations (CRO)
- Academic & Research Institutes
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Frequently Asked Questions
From 2022 to 2032, the pharmaceutical caps and closures market is poised to grow at a CAGR of 5.7%
By 2032, the pharmaceutical caps and closures market is expected to reach US$ 4 Billion
The U.S is considered highly lucrative, accounting for over 89% of the North American market
Pharmaceutical and biotechnology companies are the most prominent end users, capturing 52.5% revenue
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Packaging Innovation / Development Trends
3.3. Light weight packaging trends
3.4. Sustainable packaging trends
3.5. Smart connected packaging trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP outlook
4.1.2. Global Healthcare Outlook
4.1.3. Global Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Advanced Therapeutic Product Launches with Injectable Formulations
4.2.2. Packaging Material and Technological Advancements
4.2.3. COVID19 Pandemic Emergence
4.2.4. Cost of the Caps & Closures
4.2.5. Increases Prevalence of Chronic Disease
4.2.6. Regulatory Policies of Tamper Evident & Child Resistance Packaging
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Value Chain Analysis
5. Market Context
5.1. Global Consumption Analysis, By Countries
5.2. Product USPs/ Features
5.3. Product Adoption / Usage Analysis
5.4. Product Adoption Vs. Therapeutic Class Matrix Analysis
5.5. Promotional Strategies, Key Manufacturers
5.6. Regulatory Scenario
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product Type
6.4.2. Revenue By Therapeutic Class
6.4.3. Revenue By End User
6.4.4. Revenue By Region
6.5. 2021 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Pharmaceutical Caps & Closure Market Demand (In Volume Units) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market (Volume) Analysis, 2016-2020
7.2. Current and Future Market (Volume) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute Opportunity Analysis
7.2.2.1. By Product Type
7.2.2.2. By Functionality
7.2.2.3. Therapeutic Class
7.2.2.4. By End User
7.2.2.5. By Region
8. Global Pharmaceutical Caps & Closure Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product Type
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Pharmaceutical Caps & Closure Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Opportunity Analysis, 2021-2031
10. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (units) Analysis By Product Type, 2016-2020
10.3. Current and Future Market Size (US$ Mn) and Volume (units) Analysis and Forecast By Product Type, 2021-2031
10.3.1. Screw Caps & Closure
10.3.2. Snap Caps & Closure
10.3.3. Push-Pull Caps & Closure
10.3.4. Stopper & Seals
10.3.5. Others
10.4. Market Attractiveness Analysis By Product Type
11. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Functionality
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Functionality, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Functionality, 2021-2031
11.3.1. Child Resistant
11.3.2. Tamper evident
11.3.3. Child Resistant Tamper evident
11.3.4. Others
11.4. Market Attractiveness Analysis By Functionality
12. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Material
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Material, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2021-2031
12.3.1. Plastics
12.3.1.1. Polypropylene
12.3.1.2. High Density Poly Ethylene (HDPE)
12.3.1.3. Low-density polyethylene (LDPE)
12.3.1.4. Cyclic Olefin Copolymer (COC)
12.3.1.5. Others
12.3.2. Elastomer
12.3.2.1. Synthetic Elastomer (Petroleum)
12.3.2.2. Natural Elastomer (Rubber)
12.3.3. Metal
12.3.3.1. Aluminium
12.3.3.2. Tinplate steel
12.4. Market Attractiveness Analysis By Material
13. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Availability
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Availability, 2016-2020
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Availability, 2021-2031
13.3.1. Prescription (Rx) Pharmaceuticals
13.3.2. Over-the-Counter (OTC) Pharmaceuticals
13.4. Market Attractiveness Analysis By Availability
14. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Drug Modality
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Drug Modality, 2016-2020
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Modality, 2021-2031
14.3.1. Small Molecule (Synthetic Drugs)
14.3.2. Biopharmaceuticals
14.3.2.1. Recombinant Peptides & Proteins
14.3.2.2. Monoclonal Antibodies (mAb)
14.3.2.3. Vaccines
14.3.2.4. Gene Therapeutics
14.3.2.5. Cell & Gene Therapy (CGT)
14.3.2.6. Antibody-drug Conjugate (ADC)
14.4. Market Attractiveness Analysis By Drug Modality
15. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Class
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Class, 2016-2020
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Class, 2021-2031
15.3.1. Anticancer Drugs
15.3.2. Anti-infective Drugs
15.3.2.1. Anti-viral Drugs
15.3.2.2. Anti-bacterial Drugs
15.3.2.3. Anti-fungal Drugs
15.3.2.4. Others
15.3.3. Cardiovascular Drugs
15.3.4. Anti-inflammatory Drugs
15.3.5. Analgesics Drugs
15.3.6. Anti-diabetics
15.3.7. Ophthalmic Drugs
15.3.8. Neurological Drugs
15.3.9. Others
15.4. Market Attractiveness Analysis By Therapeutic Class
16. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By End User
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
16.3.1. Pharmaceutical & Biotechnology Companies
16.3.2. Contract Manufacturing Organizations (CMO)
16.3.3. Contract Research Organizations (CRO)
16.3.4. Academic & Research Institutes
16.4. Market Attractiveness Analysis By End User
17. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Region
17.1. Introduction
17.2. Historical Pharmaceutical Caps & Closure Market (US$ Mn) and Volume (units) Analysis By Region, 2015 - 2019
17.3. Current Pharmaceutical Caps & Closure Market (US$ Mn) and Volume (units) Analysis and Forecast By Region, 2020 - 2030
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. East Asia
17.3.5. South Asia
17.3.6. Oceania
17.3.7. Middle East and Africa (MEA)
17.4. Market Attractiveness Analysis By Region
18. North America Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. U.S.
18.3.1.2. Canada
18.3.2. By Product Type
18.3.3. By Functionality
18.3.4. By Material
18.3.5. By Availability
18.3.6. By Drug Modality
18.3.7. By Therapeutic Class
18.3.8. By End user
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
19. Latin America Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. Brazil
19.3.1.2. Mexico
19.3.1.3. Argentina
19.3.1.4. Rest of Latin America
19.3.2. By Product Type
19.3.3. By Functionality
19.3.4. By Material
19.3.5. By Availability
19.3.6. By Drug Modality
19.3.7. By Therapeutic Class
19.3.8. By End user
19.4. Market Attractiveness Analysis
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
20. Europe Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
20.3. Market Value (US$ Mn) Forecast By Market Taxonomy2021-2031
20.3.1. By Country
20.3.1.1. Germany
20.3.1.2. Italy
20.3.1.3. France
20.3.1.4. U.K.
20.3.1.5. Spain
20.3.1.6. Russia
20.3.1.7. Rest of Europe
20.3.2. By Product Type
20.3.3. By Functionality
20.3.4. By Material
20.3.5. By Availability
20.3.6. By Drug Modality
20.3.7. By Therapeutic Class
20.3.8. By End user
20.4. Market Attractiveness Analysis
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
21. South Asia Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
21.1. Introduction
21.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
21.3. Market Value (US$ Mn) Forecast By Market Taxonomy2021-2031
21.3.1. By Country
21.3.1.1. India
21.3.1.2. Thailand
21.3.1.3. Indonesia
21.3.1.4. Malaysia
21.3.1.5. Rest of South Asia
21.3.2. By Product Type
21.3.3. By Functionality
21.3.4. By Material
21.3.5. By Availability
21.3.6. By Drug Modality
21.3.7. By Therapeutic Class
21.3.8. By End user
21.4. Market Attractiveness Analysis
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
22. East Asia Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
22.1. Introduction
22.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
22.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031
22.3.1. By Country
22.3.1.1. China
22.3.1.2. Japan
22.3.1.3. South Korea
22.3.2. By Product Type
22.3.3. By Functionality
22.3.4. By Material
22.3.5. By Availability
22.3.6. By Drug Modality
22.3.7. By Therapeutic Class
22.3.8. By End user
22.4. Market Attractiveness Analysis
22.5. Market Trends
22.6. Key Market Participants - Intensity Mapping
23. Oceania Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
23.1. Introduction
23.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
23.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031
23.3.1. By Country
23.3.1.1. Australia
23.3.1.2. New Zealand
23.3.2. By Product Type
23.3.3. By Functionality
23.3.4. By Material
23.3.5. By Availability
23.3.6. By Drug Modality
23.3.7. By Therapeutic Class
23.3.8. By End user
23.4. Market Attractiveness Analysis
23.5. Market Trends
23.6. Key Market Participants - Intensity Mapping
24. Middle East and Africa Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
24.1. Introduction
24.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2016-2020
24.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2021-2031
24.3.1. By Country
24.3.1.1. GCC Countries
24.3.1.2. Turkey
24.3.1.3. South Africa
24.3.1.4. Rest of Middle East and Africa
24.3.2. By Product Type
24.3.3. By Functionality
24.3.4. By Material
24.3.5. By Availability
24.3.6. By Drug Modality
24.3.7. By Therapeutic Class
24.3.8. By End user
24.4. Market Attractiveness Analysis
24.5. Market Trends
25. Key & Emerging Countries Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031
25.1. U.S. Pharmaceutical Caps & Closure Market Analysis
25.1.1. By Product Type
25.1.2. By Functionality
25.1.3. By Material
25.1.4. By Availability
25.1.5. By Drug Modality
25.1.6. By Therapeutic Class
25.1.7. By End user
25.2. Canada Pharmaceutical Caps & Closure Market Analysis
25.2.1. By Product Type
25.2.2. By Functionality
25.2.3. By Material
25.2.4. By Availability
25.2.5. By Drug Modality
25.2.6. By Therapeutic Class
25.2.7. By End user
25.3. By End User Brazil Pharmaceutical Caps & Closure Market Analysis
25.3.1. By Product Type
25.3.2. By Functionality
25.3.3. By Material
25.3.4. By Availability
25.3.5. By Drug Modality
25.3.6. By Therapeutic Class
25.3.7. By End user
25.4. Mexico Pharmaceutical Caps & Closure Market Analysis
25.4.1. By Product Type
25.4.2. By Functionality
25.4.3. By Material
25.4.4. By Availability
25.4.5. By Drug Modality
25.4.6. By Therapeutic Class
25.4.7. By End user
25.5. U.K. Pharmaceutical Caps & Closure Market Analysis
25.5.1. By Product Type
25.5.2. By Functionality
25.5.3. By Material
25.5.4. By Availability
25.5.5. By Drug Modality
25.5.6. By Therapeutic Class
25.5.7. By End user
25.6. Germany Pharmaceutical Caps & Closure Market Analysis
25.6.1. By Product Type
25.6.2. By Functionality
25.6.3. By Material
25.6.4. By Availability
25.6.5. By Drug Modality
25.6.6. By Therapeutic Class
25.6.7. By End user
25.7. France Pharmaceutical Caps & Closure Market Analysis
25.7.1. By Product Type
25.7.2. By Functionality
25.7.3. By Material
25.7.4. By Availability
25.7.5. By Drug Modality
25.7.6. By Therapeutic Class
25.7.7. By End user
25.8. Italy Pharmaceutical Caps & Closure Market Analysis
25.8.1. By Product Type
25.8.2. By Functionality
25.8.3. By Material
25.8.4. By Availability
25.8.5. By Drug Modality
25.8.6. By Therapeutic Class
25.8.7. By End user
25.9. Spain Pharmaceutical Caps & Closure Market Analysis
25.9.1. By Product Type
25.9.2. By Functionality
25.9.3. By Material
25.9.4. By Availability
25.9.5. By Drug Modality
25.9.6. By Therapeutic Class
25.9.7. By End user
25.10. Russia Pharmaceutical Caps & Closure Market Analysis
25.10.1. By Product Type
25.10.2. By Functionality
25.10.3. By Material
25.10.4. By Availability
25.10.5. By Drug Modality
25.10.6. By Therapeutic Class
25.10.7. By End user
25.11. China Pharmaceutical Caps & Closure Market Analysis
25.11.1. By Product Type
25.11.2. By Functionality
25.11.3. By Material
25.11.4. By Availability
25.11.5. By Drug Modality
25.11.6. By Therapeutic Class
25.11.7. By End user
25.12. Japan Pharmaceutical Caps & Closure Market Analysis
25.12.1. By Product Type
25.12.2. By Functionality
25.12.3. By Material
25.12.4. By Availability
25.12.5. By Drug Modality
25.12.6. By Therapeutic Class
25.12.7. By End user
25.13. South Korea Pharmaceutical Caps & Closure Market Analysis
25.13.1. By Product Type
25.13.2. By Functionality
25.13.3. By Material
25.13.4. By Availability
25.13.5. By Drug Modality
25.13.6. By Therapeutic Class
25.13.7. By End user
25.14. ASEAN Pharmaceutical Caps & Closure Market Analysis
25.14.1. By Product Type
25.14.2. By Functionality
25.14.3. By Material
25.14.4. By Availability
25.14.5. By Drug Modality
25.14.6. By Therapeutic Class
25.14.7. By End user
25.15. Australia Pharmaceutical Caps & Closure Market Analysis
25.15.1. By Product Type
25.15.2. By Functionality
25.15.3. By Material
25.15.4. By Availability
25.15.5. By Drug Modality
25.15.6. By Therapeutic Class
25.15.7. By End user
25.16. New Zealand Pharmaceutical Caps & Closure Market Analysis
25.16.1. By Product Type
25.16.2. By Functionality
25.16.3. By Material
25.16.4. By Availability
25.16.5. By Drug Modality
25.16.6. By Therapeutic Class
25.16.7. By End user
25.17. GCC Countries Pharmaceutical Caps & Closure Market Analysis
25.17.1. By Product Type
25.17.2. By Functionality
25.17.3. By Material
25.17.4. By Availability
25.17.5. By Drug Modality
25.17.6. By Therapeutic Class
25.17.7. By End user
25.18. South Africa Pharmaceutical Caps & Closure Market Analysis
25.18.1. By Product Type
25.18.2. By Functionality
25.18.3. By Material
25.18.4. By Availability
25.18.5. By Drug Modality
25.18.6. By Therapeutic Class
25.18.7. By End user
26. Market Structure Analysis
26.1. Market Analysis by Tier of Companies
26.2. Market Share Analysis of Top Players
26.3. Market Presence Analysis
26.3.1. Regional Footprint by Players
26.3.2. Product Foot print by Players
27. Competition Analysis
27.1. Competition Dashboard
27.2. Competition Benchmarking
27.3. Competition Deep Dive (Tentative List)
27.3.1. Berry Global Group Inc.
27.3.1.1. Overview
27.3.1.2. Product Portfolio
27.3.1.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.1.4. Sales Footprint
27.3.1.5. Strategy Overview
27.3.1.5.1. Marketing Strategy
27.3.1.5.2. Product Strategy
27.3.1.5.3. Channel Strategy
27.3.2. WestRock Company
27.3.2.1. Overview
27.3.2.2. Product Portfolio
27.3.2.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.2.4. Sales Footprint
27.3.2.5. Strategy Overview
27.3.2.5.1. Marketing Strategy
27.3.2.5.2. Product Strategy
27.3.2.5.3. Channel Strategy
27.3.3. West Pharmaceutical Services, Inc.
27.3.3.1. Overview
27.3.3.2. Product Portfolio
27.3.3.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.3.4. Sales Footprint
27.3.3.5. Strategy Overview
27.3.3.5.1. Marketing Strategy
27.3.3.5.2. Product Strategy
27.3.3.5.3. Channel Strategy
27.3.4. AptarGroup, Inc.
27.3.4.1. Overview
27.3.4.2. Product Portfolio
27.3.4.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.4.4. Sales Footprint
27.3.4.5. Strategy Overview
27.3.4.5.1. Marketing Strategy
27.3.4.5.2. Product Strategy
27.3.4.5.3. Channel Strategy
27.3.5. Amcor Plc.
27.3.5.1. Overview
27.3.5.2. Product Portfolio
27.3.5.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.5.4. Sales Footprint
27.3.5.5. Strategy Overview
27.3.5.5.1. Marketing Strategy
27.3.5.5.2. Product Strategy
27.3.5.5.3. Channel Strategy
27.3.6. Gerresheimer AG
27.3.6.1. Overview
27.3.6.2. Product Portfolio
27.3.6.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.6.4. Sales Footprint
27.3.6.5. Strategy Overview
27.3.6.5.1. Marketing Strategy
27.3.6.5.2. Product Strategy
27.3.6.5.3. Channel Strategy
27.3.7. Crown Holdings, Inc.
27.3.7.1. Overview
27.3.7.2. Product Portfolio
27.3.7.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.7.4. Sales Footprint
27.3.7.5. Strategy Overview
27.3.7.5.1. Marketing Strategy
27.3.7.5.2. Product Strategy
27.3.7.5.3. Channel Strategy
27.3.8. O. Berk Company, LLC
27.3.8.1. Overview
27.3.8.2. Product Portfolio
27.3.8.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.8.4. Sales Footprint
27.3.8.5. Strategy Overview
27.3.8.5.1. Marketing Strategy
27.3.8.5.2. Product Strategy
27.3.8.5.3. Channel Strategy
27.3.9. C.L. Smith Company
27.3.9.1. Overview
27.3.9.2. Product Portfolio
27.3.9.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.9.4. Sales Footprint
27.3.9.5. Strategy Overview
27.3.9.5.1. Marketing Strategy
27.3.9.5.2. Product Strategy
27.3.9.5.3. Channel Strategy
27.3.10. Drug Plastics & Glass Co Inc.
27.3.10.1. Overview
27.3.10.2. Product Portfolio
27.3.10.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.10.4. Sales Footprint
27.3.10.5. Strategy Overview
27.3.10.5.1. Marketing Strategy
27.3.10.5.2. Product Strategy
27.3.10.5.3. Channel Strategy
27.3.11. MOLD-RITE Plastics, LLC
27.3.11.1. Overview
27.3.11.2. Product Portfolio
27.3.11.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.11.4. Sales Footprint
27.3.11.5. Strategy Overview
27.3.11.5.1. Marketing Strategy
27.3.11.5.2. Product Strategy
27.3.11.5.3. Channel Strategy
27.3.12. Aludium Group
27.3.12.1. Overview
27.3.12.2. Product Portfolio
27.3.12.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.12.4. Sales Footprint
27.3.12.5. Strategy Overview
27.3.12.5.1. Marketing Strategy
27.3.12.5.2. Product Strategy
27.3.12.5.3. Channel Strategy
27.3.13. United Caps Luxembourg S. A.
27.3.13.1. Overview
27.3.13.2. Product Portfolio
27.3.13.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.13.4. Sales Footprint
27.3.13.5. Strategy Overview
27.3.13.5.1. Marketing Strategy
27.3.13.5.2. Product Strategy
27.3.13.5.3. Channel Strategy
27.3.14. Weener Plastics Group B.V.
27.3.14.1. Overview
27.3.14.2. Product Portfolio
27.3.14.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.14.4. Sales Footprint
27.3.14.5. Strategy Overview
27.3.14.5.1. Marketing Strategy
27.3.14.5.2. Product Strategy
27.3.14.5.3. Channel Strategy
27.3.15. MENSHEN GmbH & Co. KG
27.3.15.1. Overview
27.3.15.2. Product Portfolio
27.3.15.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.15.4. Sales Footprint
27.3.15.5. Strategy Overview
27.3.15.5.1. Marketing Strategy
27.3.15.5.2. Product Strategy
27.3.15.5.3. Channel Strategy
27.3.16. BERICAP Holding GmbH
27.3.16.1. Overview
27.3.16.2. Product Portfolio
27.3.16.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.16.4. Sales Footprint
27.3.16.5. Strategy Overview
27.3.16.5.1. Marketing Strategy
27.3.16.5.2. Product Strategy
27.3.16.5.3. Channel Strategy
27.3.17. Albéa Group
27.3.17.1. Overview
27.3.17.2. Product Portfolio
27.3.17.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.17.4. Sales Footprint
27.3.17.5. Strategy Overview
27.3.17.5.1. Marketing Strategy
27.3.17.5.2. Product Strategy
27.3.17.5.3. Channel Strategy
27.3.18. DWK Life Sciences GmbH
27.3.18.1. Overview
27.3.18.2. Product Portfolio
27.3.18.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.18.4. Sales Footprint
27.3.18.5. Strategy Overview
27.3.18.5.1. Marketing Strategy
27.3.18.5.2. Product Strategy
27.3.18.5.3. Channel Strategy
27.3.19. Yantai Hicap Closures Co., Ltd.
27.3.19.1. Overview
27.3.19.2. Product Portfolio
27.3.19.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.19.4. Sales Footprint
27.3.19.5. Strategy Overview
27.3.19.5.1. Marketing Strategy
27.3.19.5.2. Product Strategy
27.3.19.5.3. Channel Strategy
27.3.20. Parekhplast India Limited
27.3.20.1. Overview
27.3.20.2. Product Portfolio
27.3.20.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.20.4. Sales Footprint
27.3.20.5. Strategy Overview
27.3.20.5.1. Marketing Strategy
27.3.20.5.2. Product Strategy
27.3.20.5.3. Channel Strategy
27.3.21. Manaksia Limited
27.3.21.1. Overview
27.3.21.2. Product Portfolio
27.3.21.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.21.4. Sales Footprint
27.3.21.5. Strategy Overview
27.3.21.5.1. Marketing Strategy
27.3.21.5.2. Product Strategy
27.3.21.5.3. Channel Strategy
27.3.22. Parshva Exim Limited
27.3.22.1. Overview
27.3.22.2. Product Portfolio
27.3.22.3. Profitability by Market Segments (Product/Channel/Regional)
27.3.22.4. Sales Footprint
27.3.22.5. Strategy Overview
27.3.22.5.1. Marketing Strategy
27.3.22.5.2. Product Strategy
27.3.22.5.3. Channel Strategy
28. Assumptions and Acronyms Used
29. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 2: Global Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 3: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 4: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 5: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 6: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 7: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 8: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 9: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 10: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 11: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031 By Region
Table 12: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 13: North America Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 14: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 15: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 16: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 17: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 18: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 19: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 20: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 21: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 22: North America Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 23: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 24: Latin America Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 25: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 26: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 27: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 28: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 29: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 30: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 31: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 32: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 33: Latin America Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 34: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 35: Europe Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 36: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 37: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 38: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 39: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 40: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 41: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 42: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 43: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 44: Europe Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 45: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 46: South Asia Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 47: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 48: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 49: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 50: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 51: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 52: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 53: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 54: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 55: South Asia Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 56: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 57: East Asia Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 58: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 59: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 60: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 61: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 62: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 63: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 64: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 65: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 66: East Asia Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 67: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 68: Oceania Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 69: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 70: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 71: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 72: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 73: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 74: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 75: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 76: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 77: Oceania Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Table 78: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 79: Middle East and Africa Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product
Table 80: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality
Table 81: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 82: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material
Table 83: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability
Table 84: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality
Table 85: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 86: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class
Table 87: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User
Table 88: Middle East and Africa Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Pharmaceutical Caps & Closure Market Volume (in Units), 2016-2020
Figure 02: Global Pharmaceutical Caps & Closure Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2021–2031
Figure 03: Pharmaceutical Caps & Closure, Pricing Analysis per unit (US$), in 2020
Figure 04: Pharmaceutical Caps & Closure, Pricing Forecast per unit (US$), in 2031
Figure 05: Global Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016-2020
Figure 06: Global Pharmaceutical Caps & Closure Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021–2031
Figure 07: Global Pharmaceutical Caps & Closure Market Absolute $ Opportunity, 2020 - 2031
Figure 08: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Product, 2021 & 2031
Figure 09: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Product, 2021-2031
Figure 10: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Product, 2021-2031
Figure 11: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Functionality, 2021 & 2031
Figure 12: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Functionality, 2021-2031
Figure 13: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Functionality, 2021-2031
Figure 14: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Material, 2021 & 2031
Figure 15: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Material, 2021-2031
Figure 16: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Material, 2021-2031
Figure 17: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Availability, 2021 & 2031
Figure 18: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Availability, 2021-2031
Figure 19: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Availability, 2021-2031
Figure 20: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Drug Modality, 2021 & 2031
Figure 21: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Drug Modality, 2021-2031
Figure 22: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Drug Modality, 2021-2031
Figure 23: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Therapeutic Class, 2021 & 2031
Figure 24: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Therapeutic Class, 2021-2031
Figure 25: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Therapeutic Class, 2021-2031
Figure 26: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By End User, 2021 & 2031
Figure 27: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By End User, 2021-2031
Figure 28: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by End User, 2021-2031
Figure 29: Global Pharmaceutical Caps & Closure Market Share Analysis (%) By Region, 2021 & 2031
Figure 30: Global Pharmaceutical Caps & Closure Market Y-o-Y Growth (%) By Region, 2021–2031
Figure 31: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis By Region, 2021–2031
Figure 32: North America Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 33: North America Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 34: North America Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 35: North America Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 36: North America Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 37: North America Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 38: North America Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 39: North America Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 40: North America Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 41: North America Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 42: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 43: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 44: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 45: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 46: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 47: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 48: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 49: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 50: Latin America Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 51: Latin America Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 52: Latin America Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 53: Latin America Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 54: Latin America Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 55: Latin America Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 56: Latin America Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 57: Latin America Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 58: Latin America Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 59: Latin America Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 60: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 61: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 62: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 63: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 64: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 65: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 66: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 67: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 68: Europe Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 69: Europe Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 70: Europe Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 71: Europe Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 72: Europe Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 73: Europe Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 74: Europe Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 75: Europe Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 76: Europe Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 77: Europe Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 78: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 79: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 80: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 81: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 82: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 83: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 84: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 85: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 86: South Asia Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 87: South Asia Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 88: South Asia Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 89: South Asia Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 90: South Asia Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 91: South Asia Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 92: South Asia Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 93: South Asia Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 94: South Asia Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 95: South Asia Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 96: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 97: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 98: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 99: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 100: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 101: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 102: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 103: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 104: East Asia Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 105: East Asia Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 106: East Asia Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 107: East Asia Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 108: East Asia Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 109: East Asia Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 110: East Asia Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 111: East Asia Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 112: East Asia Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 113: East Asia Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 114: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 115: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 116: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 117: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 118: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 119: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 120: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 121: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 122: Oceania Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 123: Oceania Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 124: Oceania Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 125: Oceania Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 126: Oceania Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 127: Oceania Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 128: Oceania Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 129: Oceania Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 130: Oceania Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 131: Oceania Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 132: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 133: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 134: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 135: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 136: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 137: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 138: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 139: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 140: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Product (2021E)
Figure 141: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)
Figure 142: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Material (2021E)
Figure 143: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)
Figure 144: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)
Figure 145: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)
Figure 146: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By End User (2021E)
Figure 147: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Country (2021E)
Figure 148: Middle East and Africa Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020
Figure 149: Middle East and Africa Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031
Figure 150: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031
Figure 151: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031
Figure 152: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031
Figure 153: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031
Figure 154: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031
Figure 155: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031
Figure 156: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031
Figure 157: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031
Figure 158: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 159: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 160: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 161: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 162: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 163: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 164: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 165: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 166: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 167: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 168: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 169: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 170: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 171: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 172: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 173: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 174: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 175: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 176: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 177: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 178: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 179: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 180: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 181: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 182: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 183: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 184: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 185: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 186: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 187: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 188: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 189: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 190: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 191: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 192: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 193: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 194: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 195: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 196: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 197: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 198: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 199: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 200: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 201: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 202: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 203: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 204: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 205: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 206: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 207: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 208: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 209: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 210: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 211: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 212: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 213: France Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 214: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 215: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 216: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 217: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 218: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 219: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 220: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 221: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 222: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 223: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 224: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 225: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 226: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 227: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 228: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 229: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 230: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 231: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 232: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 233: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 234: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 235: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 236: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 237: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 238: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 239: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 240: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 241: China Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 242: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 243: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 244: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 245: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 246: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 247: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 248: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 249: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 250: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 251: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 252: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 253: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 254: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 255: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 256: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 257: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 258: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 259: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 260: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 261: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 262: India Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 263: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 264: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 265: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 266: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 267: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 268: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 269: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 270: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 271: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 272: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 273: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 274: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 275: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 276: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 277: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 278: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 279: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 280: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 281: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 282: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 283: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 284: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 285: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 286: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 287: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 288: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 289: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 290: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 291: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 292: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 293: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 294: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 295: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 296: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 297: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 298: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 299: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 300: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 301: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 302: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 303: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 304: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 305: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 306: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 307: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 308: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 309: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 310: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 311: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Figure 312: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031
Figure 313: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031
Figure 314: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031
Figure 315: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031
Figure 316: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031
Figure 317: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031
Figure 318: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
